Jakub Hlávka, Ph.D. is Director of the Health Economics, Policy and Innovation Institute (HEPII) at Masaryk University, Czech Republic, and a Clinical Associate Professor (Adjunct) of Population and Public Health Sciences at the University of Southern California (USC). He is also a Non-Resident Fellow at the Leonard D. Schaeffer Center for Health Policy & Economics at USC. His interests include Alzheimer's disease and the economics of aging, innovative payment for emerging therapies, incl. cell and gene therapies in oncology, neurology and cardiovascular disease, health system reform and the study of inequality, and resilience and preparedness in both healthcare and national security.
Jakub Hlávka holds a PhD from the Pardee RAND Graduate School, a master’s degree from Georgetown University, Edmund A. Walsh School of Foreign Service, and an undergraduate degree from the University of Economics in Prague.

Jakub Červený has been an assistant professor at HEPII since 2024 and also works at the Institute of Health Analyses of the Ministry of Health of the Slovak Republic. His research involves applied microeconometrics with a focus on health and labour economics. He is interested in topics such as: survival/duration analysis, regional differences in health care utilization and quality, drug co-payments and competition in health care. He got his Doctor degree in 2017 at Universiteit van Tilburg in the Netherlands and then held a post-doc position at the Department of Health Economics at Medizinische Universität Wien.

Michal Stanak is a researcher at MUNI. He is a founding director of the National Institute for Value and Technology in Healthcare, a Slovak national HTA body. From 2015 to 2020, he worked as an HTA researcher at the Austrian Institute for HTA.

Michal studied in England and Austria. He earned a bachelor's degree in the field of Philosophy at King's College London, a master's degree in Politics, Philosophy and Health Economics at University College London and a doctorate in Applied Ethics in the field of decision-making processes in health care at University of Vienna.

Matej is a researcher at the Health Economics, Policy and Innovation Institute (HEPII) at the Masaryk University and is also pursuing a PhD under the supervision of Jakub Hlávka. He studied economics with a focus on competition and regulation in healthcare at Tilburg University and Vienna University of Economics and Business. In the past, he headed the analytical unit of the Slovak Ministry of Health (Institute for Healthcare Analysis), served as a member of the supervisory boards of the National Institute for Cardiovascular Diseases and the Eastslovakia’s Institute for Cardiovascular Diseases, and represented Slovakia at OECD and European Commission health forums.